0001562180-22-006665.txt : 20220914 0001562180-22-006665.hdr.sgml : 20220914 20220914180431 ACCESSION NUMBER: 0001562180-22-006665 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220912 FILED AS OF DATE: 20220914 DATE AS OF CHANGE: 20220914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linetsky David CENTRAL INDEX KEY: 0001776729 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38977 FILM NUMBER: 221243935 MAIL ADDRESS: STREET 1: C/O PHREESIA, INC. STREET 2: 432 PARK AVENUE S., 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phreesia, Inc. CENTRAL INDEX KEY: 0001412408 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 1521 CONCORD PIKE STREET 2: SUITE 301 PMB 221 CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 888-654-7473 MAIL ADDRESS: STREET 1: 1521 CONCORD PIKE STREET 2: SUITE 301 PMB 221 CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: Phreesia Inc DATE OF NAME CHANGE: 20070914 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-09-12 false 0001412408 Phreesia, Inc. PHR 0001776729 Linetsky David C/O PHREESIA, INC. 1521 CONCORD PIKE, SUITE 301 PMB 221 WILMINGTON DE 19803 false true false false SVP, Life Sciences Common Stock 2022-09-12 4 A false 1589.00 A 226074.00 D Common Stock 2022-09-12 4 F false 626.00 29.19 D 225448.00 D Common Stock 5683.00 I By spouse Stock Option (Right to buy) 4.71 2028-10-24 Common Stock 285.00 285.00 I By spouse Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2023 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted are based on a per share value of $29.19, the closing price of the Issuer's common stock on September 12, 2022. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of fully vested RSUs granted on September 12, 2022 and does not represent a sale by the Reporting Person. 228 of the shares subject to this option are vested as of the date hereof, and the remaining shares will vest and become exercisable in two equal installments on September 25, 2022 and October 25, 2022. /s/ Allison Hoffman by Power of Attorney for David Linetsky 2022-09-14